Implantable Cardioverter Defibrillator Clinical Trial Analysis

Summary

Global Markets Direct's "Implantable Cardioverter Defibrillator Clinical Trials Analysis" is an essential source of data and information pertaining to product clinical trials being carried out by Implantable Cardioverter Defibrillator manufacturers, globally. The report provides exhaustive information on each clinical investigation study with coverage detailed coverage on the pipeline products these trials are being carried out for.

Scope

• The report provides analysis and review of the key clinical trials being carried out globally and across key Implantable Cardioverter Defibrillator market categories - Dual Chamber Implantable Cardioverter Defibrillator,Single Chamber Implantable Cardioverter Defibrillator
• The report covers information on each product being clinically tested with detailed coverage on the pipeline product profile, the indication it's being investigated for etc.
• The report provides an in-depth analysis of the clinical trials with information on trial phase, trial 0status, trial acronym, purpose, inclusion and exclusion criteria, description, design, intervention, investigator information, primary and secondary end-points and trial results
• The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct's team of industry experts.

Reasons to Buy

• Effectively plan your Mergers and Acquisitions and partnership strategies by identifying companies with the most promising pipeline.
• Stay ahead of the information curve in the fast changing Implantable Cardioverter Defibrillator market.
• Plan in-licensing and out-licensing opportunities through review of pipeline products and technologies.
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Proactively plan and execute your competitive strategies by identifying clinical trials status of the leading competitive products in pipeline.
• Stay ahead of competition by understanding the changing competitive landscape in specific geographies.

Contents

• 1 List of Tables
• 1.2 List of Figures
• 2 Implantable Cardioverter Defibrillator Clinical Trials
  • 2.1 Implantable Cardioverter Defibrillator Clinical Trial By Equipment Type
  • 2.2 Implantable Cardioverter Defibrillator Clinical Trials By Trial Phase and Trial Status
  • 2.3 Implantable Cardioverter Defibrillator Pipeline Products By Development Stage
  • 2.4 Implantable Cardioverter Defibrillator Pipeline Products By Therapy Area
  • 2.5 Implantable Cardioverter Defibrillator Pipeline Products By News Summary
• 3 Recent Developments
  • 3.1 Product News
    • 3.1.1 Jun 10, 2009: St. Jude Medical Announces First Implant Of Current Plus ICD Featuring The SJ4 Connector System
    • 3.1.2 Apr 13, 2009: BIOTRONIK Announces First Implant Of Next-Generation Lumax Defibrillator In US
    • 3.1.3 Mar 31, 2009: Results From Medtronic-Supported Clinical Trial Assessing Use Of Implantable Cardiac Devices In Certain Heart Attack Patients Show Reduction In Sudden Cardiac Death
    • 3.1.4 Jan 06, 2009: Cameron Health Launches Clinical Trial Of Subcutaneous Implantable Defibrillator For The Treatment Of Sudden Cardiac Arrest
    • 3.1.5 Dec 16, 2008: Zoll Receives Clearance To Market R Series Code-Ready Defibrillator With WiFi Option
    • 3.1.6 Oct 24, 2008: Boston Scientific Corporation Receives Canadian Approval For TELIGEN Implantable Cardioverter Defibrillator
    • 3.1.7 Sep 23, 2008: UK'S National Health Service Supply Chain Ranks Zoll R Series Defibrillator At Highest Value
    • 3.1.8 Sep 09, 2008: Good Samaritan Health System Among First To Implant Advanced Defibrillator
    • 3.1.9 Aug 26, 2008: EchoCRT Enrolls First Patients At The Ohio State University Medical Center
    • 3.1.10 Aug 14, 2008: Cardiac To Install AEDs At American Electric
    • 3.1.11 Aug 06, 2008: Boston Scientific Announces First UK Patients To Benefit From Next-Generation Heart Devices
    • 3.1.12 Jul 31, 2008: BIOTRONIK Launches HomeCARE II Study To Evaluate Innovative Sensor Technology
    • 3.1.13 Jul 24, 2008: Nihon Kohden To Sell Automated External Defibrillators In Asia
    • 3.1.14 Mar 20, 2008: InnerPulse Incorporates The Elast-Eon Material Into Its PICD
    • 3.1.15 Nov 06, 2007: New Study Indicates Audiovisual Prompts On Cardiac Science AEDs Lead To Quality CPR By Untrained Rescuers
    • 3.1.16 Aug 31, 2007: Sorin Group Launches World's Smallest Implantable Cardioverter Defibrillators In Japan
  • 3.2 Product Approvals
    • 3.2.1 Dec 16, 2008: Zoll Receives Clearance To Market R Series Code-Ready Defibrillator With WiFi Option
    • 3.2.2 Oct 24, 2008: Boston Scientific Corporation Receives Canadian Approval For TELIGEN Implantable Cardioverter Defibrillator
  • 3.3 Clinical Trials
    • 3.3.1 Jun 10, 2009: St. Jude Medical Announces First Implant Of Current Plus ICD Featuring The SJ4 Connector System
    • 3.3.2 Mar 31, 2009: Results From Medtronic-Supported Clinical Trial Assessing Use Of Implantable Cardiac Devices In Certain Heart Attack Patients Show Reduction In Sudden Cardiac Death
    • 3.3.3 Jan 06, 2009: Cameron Health Launches Clinical Trial Of Subcutaneous Implantable Defibrillator For The Treatment Of Sudden Cardiac Arrest
    • 3.3.4 Aug 26, 2008: EchoCRT Enrolls First Patients At The Ohio State University Medical Center
    • 3.3.5 Jul 31, 2008: BIOTRONIK Launches HomeCARE II Study To Evaluate Innovative Sensor Technology
• 4 Appendix
  • 4.1 Methodology
    • 4.1.1 Coverage
    • 4.1.2 Secondary Research
    • 4.1.3 Primary Research
    • 4.1.4 Expert Panel Validation
  • 4.2 Contact Us
  • 4.3 About Global Markets Direct
  • 4.4 Disclaimer
• 1 List of Tables
  • Table 1: Implantable Cardioverter Defibrillator Clinical Trial By Equipment Type
  • Table 2: Implantable Cardioverter Defibrillator Clinical Trials By Trial Phase and Trial Status
  • Table 3: Implantable Cardioverter Defibrillator Pipeline Products By Development Stage
  • Table 4: Implantable Cardioverter Defibrillator Pipeline Products By Therapy Area
  • Table 5: Implantable Cardioverter Defibrillator Pipeline Products By News Summary
• 1.2 List of Figures
  • Figure 1: Global Markets Direct Methodology